-
41
Screening for gene variants causing inherited platelet disorders: are the cons always cons?
Published 2025-02-01Get full text
Article -
42
Oral and Dental Findings of Dyskeratosis Congenita
Published 2014-01-01“…At the age of 4, the bone marrow transplantation was performed. Dermatological findings occurred after the bone marrow transplantation. …”
Get full text
Article -
43
Erratum to “DNMT3A Mutations in Patients with Acute Myeloid Leukemia in South Brazil”
Published 2014-01-01Get full text
Article -
44
-
45
-
46
-
47
Association of Beta-Thalassaemia and Hypogonadotropic Hypogonadism
Published 2022-01-01“…We present a case of secondary amenorrhoea in a patient with beta-thalassaemia and a history of multiple therapies in her adolescence, such as multiple transfusions, chemotherapy, and allogeneic bone marrow transplantation, who presented with HH and premature ovarian insufficiency.…”
Get full text
Article -
48
Toll-Like Receptor 4 in Bone Marrow-Derived Cells Contributes to the Progression of Diabetic Retinopathy
Published 2014-01-01“…Similarly, VEGF and HIF-1α expression were restored by the bone marrow transplantation. These findings identify an essential role for TLR4 in bone marrow-derived cells contributing to the progression of DR.…”
Get full text
Article -
49
Calcinosis Cutis Associated with Chronic Sclerodermoid Graft versus Host Disease: A Case and Review of the Literature
Published 2020-01-01“…We present a rare case of calcinosis cutis associated with chronic sclerodermoid graft versus host disease in a 59-year-old male, 13 years following allogenic bone marrow transplantation. The etiology of calcification was thought to be dystrophic. …”
Get full text
Article -
50
Artificial intelligence in thrombosis: transformative potential and emerging challenges
Published 2025-01-01Get full text
Article -
51
-
52
Two Cases of Miliary Tuberculosis and Increasing Level of CA-125
Published 2006-01-01“…Additionally, sometimes the serum level of CA 125 increases spontaneously during the menstrual cycle (8,9). In bone marrow transplantation, this marker is a sensitive index in the diagnosis of veno-occlusive disease (10). …”
Get full text
Article -
53
Griscelli syndrome type 2: Rare 3 cases from Iraq
Published 2024-12-01“…We present two cases from different governorates who were diagnosed with GS by achieving genetic study: the first case was saved by successful bone marrow transplantation, whereas the second case died before managing to do the procedure, being rare and underdiagnosed disease end with misdiagnosis and mismanagement.…”
Get full text
Article -
54
Immunomodulation in the Treatment of Refractory Catastrophic Antiphospholipid Syndrome
Published 2018-01-01Get full text
Article -
55
A Case of Abdominal Sarcoidosis in a Patient with Acute Myeloid Leukemia
Published 2013-01-01“…The allogeneic bone marrow transplantation usually preceded by induction chemotherapy, in fit patients, represents the gold standard in the acute myeloid leukaemia. …”
Get full text
Article -
56
-
57
Recurrent Diffuse Large B-Cell Lymphoma with the Initial Manifestation of Retinal Involvement
Published 2023-07-01“…Hence, the patient received six cycles of systemic chemotherapy along with intrathecal chemotherapy and refused either radiation therapy or bone marrow transplantation. The patient achieved complete remission with no recurrence for 3 years until the present.…”
Get full text
Article -
58
Blood Cancer and the Heart: Light Chain Cardiomyopathy in Refractory Multiple Myeloma
Published 2022-01-01“…Her MM has been refractory to multiple chemotherapy regimens and two autologous bone marrow transplantation. Diagnostic evaluations including serum kappa and lambda chains, echocardiogram, pyrophosphate cardiac scan, and cardiac magnetic resonance were indicative of a progression to AL cardiomyopathy. …”
Get full text
Article -
59
DNMT3A Mutations in Patients with Acute Myeloid Leukemia in South Brazil
Published 2012-01-01Get full text
Article -
60
A Nomogram Based on Circulating Inflammatory Factors for Predicting Prognosis of Newly Diagnosed Multiple Myeloma Patients
Published 2025-02-01“…Mowang Wang,1– 4,* Xiaoyan Yue,5,* Yingying Ding,5,* Zhen Cai,1,4 Haowen Xiao,5 He Huang,1– 4 Jingsong He1,4 1Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, People’s Republic of China; 2Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, Zhejiang Province, People’s Republic of China; 3Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang Province, People’s Republic of China; 4Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, Zhejiang Province, People’s Republic of China; 5Department of Hematology and Cell Therapy, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, People’s Republic of China*These authors contributed equally to this workCorrespondence: He Huang; Jingsong He, Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, No. 79 Qingchun Road, Hangzhou, Zhejiang Province, 310006, People’s Republic of China, Email huanghe@zju.edu.cn; hejingsong@zju.edu.cnPurpose: The growth and survival of multiple myeloma (MM) cells depend heavily on bone marrow microenvironment, where inflammation emerges as a significant feature and is commonly associated with unfavorable prognosis in MM. …”
Get full text
Article